Moving Target: CNVs in Disease | GenomeWeb

Moving Target: CNVs in Disease


Over the past year, a slew of papers emerged linking copy number variation to a host of diseases. It's no wonder that studies linking insertions and deletions to disease etiology continue to multiply. New systems biology tools, from high-density SNP and CNV chips to next-gen sequencing, are moving scientists not only into genome-wide CNV analysis, but also to performing CNV association studies to learn how previously undetectable CNVs might contribute to disease susceptibility.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.